ImmuPharma plc (LON:IMM)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 11.15 ($0.15) and traded as low as GBX 8.20 ($0.11). ImmuPharma shares last traded at GBX 9.10 ($0.12), with a volume of 2,076,288 shares.
The company has a fifty day moving average price of GBX 8.91 and a two-hundred day moving average price of GBX 11.13. The company has a market capitalization of £25.40 million and a P/E ratio of -2.93. The company has a debt-to-equity ratio of 31.74, a current ratio of 9.51 and a quick ratio of 5.99.
ImmuPharma Company Profile (LON:IMM)
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity, anti-infectives, metabolism, and cancer. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
See Also: Cost of Equity For A Business, Investors
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.